A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 12-Week, Clinical Study Designed to Assess the Efficacy and Safety of BDP Nasal Aerosol (80 Mcg, Once Daily) in Pediatric Subjects (4 to 11 Years of Age) With PAR

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to evaluate the efficacy and safety of Beclomethasone dipropionate (BDP) nasal aerosol in subjects with Perennial Allergic Rhinitis (PAR).
Epistemonikos ID: a8f522930e76d26fe4aedb1ea32d08ab8f2094eb
First added on: May 11, 2024